Involvement of tyrosine phosphorylation in endothelin-1-induced calcium-sensitization in rat small mesenteric arteries

British Journal of Pharmacology

Volumn 120, Issue 4, 1997, Pages 653-661

  Ohanian, Jacqueline ^a   Ohanian, Vasken ^a   Shaw, Linda ^a   Bruce, Christopher ^a   Heagerty, Anthony M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Calcium sensitization; Endothelin 1; Rat mesenteric arteries; Tyrosine phosphorylation; Vascular smooth muscle

Indexed keywords

ALPHA TOXIN; CALCIUM ION; ENDOTHELIN 1; GUANOSINE TRIPHOSPHATE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE; TYRPHOSTIN;

ANIMAL TISSUE; ARTERY; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; MESENTERIC ARTERY; MOLECULAR WEIGHT; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM; CATECHOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; MESENTERIC ARTERIES; NITRILES; PHOSPHOLIPASE C; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; TYRPHOSTINS; VASOCONSTRICTION;

EID: 0031050809     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700950     Document Type: Article

References (43)

1. ABEDI, H., DAWES, K.E. & ZACHARY, I. (1995). Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J. Biol Chem., 270, 11367-11376.
2. AKIYAMA, T., ISHIDA, J., NAKAGAWA, S, OGAWARA, H., WATANABE, S., ITOH, N., SHIBUYA, M. & FUKAMI, Y. (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592-5595.
3. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. & NAKANISHI, S. (1990). Cloning and expression of cDNA encoding an endothelin receptor. Nature, 348, 730-732.
4. BRADFORD, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. DI SALVO, J., SEMENCHUK, L.A. & LAUER, J. (1993a). Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Arch. Biochem. Biophys., 304, 386-391.
6. DI SALVO, J., STEUSLOFF, A., SEMENCHUK, L., SATOH, S., KOLQUIST, K. & PFITZER, G (1993b). Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun., 190, 968-974.
7. ENOKI, T., MIWA, S., SAKAMOTO, A., MINOWA, T., KOMURO, T., KOBAYASHI, S., NINOMIYA, H. & MASAKI, T. (1995). Long-lasting activation of cation current by low concentration of endothelin-1 in mouse fibroblasts and smooth muscle cells of rabbit aorta. Br. J. Pharmacol., 115, 479-485.
8. FLEMING, I., FISSLTHALER, B. & BUSSE, R. (1995). Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circ. Res., 76, 522-529.
9. GONG, M., IIZUKA, K., NIXON, G., BROWNE, J.P., HALL, A., ECCLESTON, J.F., SUGAI, M., KOBAYASHI, S., SOMLYO, A.V. & SMOLYO, A.P. (1996). Role of guanine nucleotide-binding proteins-ras-family or trimeric proteins or both-in Ca sensitisation of smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 93, 1340-1345.
10. 2+ channel in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 86, 3915-3918.
11. HIGHSMITH, R.F., BLACKBURN, K. & SCHMIDT, D.J. (1992). Endothelin and calcium dynamics in vascular smooth muscle. Ann. Rev. Physiol., 54, 257-278.
12. HILEY, C.R. & POON, H.-Y. (1994). Effects of endothelin peptides in isolated small mesenteric arteries of the rat lack of vasodilator effect. Can. J. Physiol. Pharmacol., 72(Suppl. 1), 108.
13. HIRATA, K., KIKUCHI, A., SASAKI, T., KURODA, S., KAIBUCHI, K., MATSUURA, Y., SEK, H., SAIDA, K. & TAKAI, Y. (1992). Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J. Biol. Chem., 267, 8719-8722.
14. HOLLENBERG, M.D. (1994). Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci., 15, 108-114.
15. HORIUTI, K. (1988). Mechanisms of contracture on cooling of caffeine-treated frog skeletal muscle fibres. J. Physiol., 398, 131-148.
16. HUCKLE, W.R., DY, R.C. & EARP, H.S. (1992). Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc. Natl. Acad. Sci. U.S.A., 89, 8837-8841.
17. 2+ in rabbit isolated ear artery by platelet-derived growth factor. Br. J. Pharmacol., 114, 138-142.
18. INOUE, A., YANAGISAWA, M., KIMURA, S., KASUYA, Y., MIYAUCHI, T., GOTO, K. & MASAKI, T. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A., 86, 2863-2867.
19. 2+ sensitivity in alpha-toxin-permeabilised small mesenteric artery from the rat. Br. J. Pharmacol., 117, 1238-1244.
20. KITAZAWA, T., KOBAYASHI, S., HORIUTI, K., SOMLYO, A.V. & SOMLYO, A.P. (1989). Receptor-coupled, permeabilised smooth muscle. J. Biol. Chem., 264, 5339-5342.
21. KOIDE, M., KAWAHARA, Y., TSUDA, T., ISHIDA, T., SHII, K. & YOKOYAMA, M. (1992). Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J. Hypertens., 10, 1173-1182.
22. c-src antibodies inhibits the angiotensin II activation of phospholipase Cγ in rat aortic smooth muscle cells. J. Biol. Chem., 270, 15734-15738.
23. 2+ sensitivity in α-toxin permeabilised arterial smooth muscle. Biochem. Biophys. Res. Commun., 157, 677-683.
24. 2+ sensitivity in α-toxin permeabilized rabbit mesenteric artery. Circ. Res., 71, 951-959.
25. NODA, M., YASUDA-FUKAZAWA, C., MORIISHI, K., KATO, T., OKUDA, T., KUROKAWA, K. & TAKUWA, Y. (1995). Involvement of rho in GTPγS-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett., 367, 246-250.
26. OHANIAN, J., IZZARD, A., LITTLEWOOD, M. & HEAGERTY, A.M. (1993). Regulation of diacylglycerol metabolism by vasoconstrictor hormones in intact small arteries. Circ. Res., 72, 1163-1171.
27. SAKATA, K., OZAKI, H., KWON, S.-C. & KARAKI, H. (1989). Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscle. Br. J. Pharmacol., 98, 483-492.
28. SAKURAI, T., YANAGISAWA, M., TAKUWA, T., MIYAZAKI, H., KIMURA, S., GOTTO, K. & MASAKI, T. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature, 348, 732-735.
29. 2+-responsiveness of smooth muscle contraction. FEBS Lett., 324, 211-215.
30. SIMONSON, M.S. & DUNN, M.J. (1990). Cellular signaling by peptides of the endothelin gene family. FASEB J., 4, 2989-3000.
31. SIMONSON, M.S. & HERMAN, W.H. (1993). Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J. Biol. Chem., 268, 9347-9357.
32. 2+ channels mediate protein tyrosine kinase activation by endothelin-1. Am. J. Physiol., 270, F790-F797.
33. SOMLYO, A.P. & SOMLYO, A.V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231-236.
34. TOMA, C., JENSEN, P.E., PRIETO, D., HUGHES, A., MULVANY, M.J. & AALKJAER, C. (1995). Effects of tyrosine inhibitors on the contractility of rat mesenteric arteries. Br. J. Pharmacol., 114, 1266-1272.
35. TOWBIN, H., STAEHELIN, T. & GORDON, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc. Natl. Acad. Sci. U.S.A., 76, 4350-4354.
36. TSUDA, T., KAWAHARA, Y., SHII, K., KOIDE, M., ISHIDA, Y. & YOKOYAMA, M. (1991). Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett., 285, 44-48.
37. WARD, D.T., OHANIAN, J., HEAGERTY, A.M. & OHANIAN, V. (1995). Phospholipase D-induced phosphatide production in intact small arteries during noradrenaline stimulation: involvement of both G-protein and tyrosine-phosphorylation-linked pathways. Biochem. J., 307, 451-456.
38. WARNER, T.D., ALLCOCK, G.H., CORDER, R. & VANE, J.R. (1993). Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br. J. Pharmacol., 110, 777-782.
39. c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 217, 1039-1044.
40. WIJETUNGE, S., AALKJAER, C., SCHACHTER, M. & HUGHES, A.D. (1992). Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 189, 1620-1623.
41. 2+ mobilization in smooth muscle cells by protein kinase C. Am. J. Physiol., 266, C1560-C1567.
42. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
43. ZACHARY, I., SINNETT-SMITH, J. & ROZENGURT, E. (1992). Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. J. Biol. Chem., 267, 19031-19034.